| First author, year | Sample | Mean age (range) (y) | Follow-up | TSH cutoff value (mIU/L) (Shypo/Shyper) | Thyroxine measured (Shypo/Shyper) | Exclusion of thyroid hormone/antithyroid drug recipients | Outcome (Shypo or Shyper) |
| Parle et al. [43] | 1187 | 70.4 (>60) | 8.2 y | >5.0/<0.44 | Yes/yes | Yes/yes | CHD, CHD mortality, total, and cardiovascular mortality | Gussekloo et al. [42] | 527 | 85 | 3.7 y | >4.8/<0.3 | Yes/yes | Yes/yes | CHD, CHD mortality, total, and cardiovascular mortality | Rodondi et al. [41] | 2730 | 74.7 (70–79) | 4 y | ≥4.5/NA | Yes/NA | NR/NA | CHD, HF, total, and cardiovascular mortality | Walsh et al. [24] | 1890 | 49.8 (17–89) | 20 y | >4.0/<0.4 | Yes/yes | NR/NR | CHD and cardiovascular mortality | Cappola et al. [23] | 3182 | 72.7 (≥65) | 12.5 y | >4.5/<0.45 | Yes/yes | Yes/yes | CHD, AF, total, and cardiovascular mortality | Bauer et al. [40] | 487 | 71.7 (≥65) | 11.9 y | >5.5/≤0.5 | NR/NR | NR/NR | Total and cardiovascular mortality | Rodondi et al. [39] | 3044 | 72.6 (≥65) | 15 y | >4.5/<0.45 | Yes/yes | Yes/yes | HF | Razvi et al. [38] | 2350 | 45.4 (18–92) | 20 y | >6/NA | NR/NA | Yes/NA | CHD, CHD mortality, and total mortality | Boekholdt et al. [5] | 13,141 | 58 (45–79) | 10.6 y | >4/<0.4 | Yes/yes | Yes/yes | CHD, CHD mortality, and total mortality | Ittermann et al. [44] | 3883 | 48.9 (20–79) | 8.5 y | NA/<0.25 | NA/yes | NA/yes | CHD, CHD mortality, AF, and total mortality | Jongh et al. [21] | 1197 | 75.5 (>65) | 10.7 y | >4.5/<0.3 | Yes/yes | Yes/yes | CHD, CHD mortality, total, and cardiovascular mortality | Schultz et al. [35] | 605 | 67.8 (50–91) | 5 y | >4/<0.4 | Yes/yes | NR/NR | Total mortality | Nanchen et al. [33] | 5316 | 75 (70–82) | 3.2 y | ≥4.5/<0.45 | Yes/yes | Yes/yes | CHD, HF, AF, total, and cardiovascular mortality | Asvold et al. [34] | 26,475 | 53.7 | 12.3 y | >3.6/<0.49 | Yes/yes | NR/NR | CHD, CHD mortality, and HF | Ceresini et al. [32] | 931 | 75.5 (>65) | 6 y | >4.68/<0.49 | Yes/yes | Yes/yes | Total mortality | Hyland et al. [31] | 4863 | 73.5 (>65) | 10 y | >4.5/NA | Yes/NA | NR/NA | CHD, cardiovascular mortality, and HF |
|
|